PSI

   |   

   |   

   |   

   |   


Home PSI About Us Full Service Contract Research Organization (CRO) Global Reach On-Time Enrollment Therapeutic Excellence Contract Research Organization (CRO) News

Case Studies     |     Allergy, Immunology & Rheumatology    |    Cardiology      |     Central Nervous System     |    Endocrine & Metabolic     |     Gastroenterology

Hematology     |     Infectious Disease     |     Oncology     |     Nephrology & Urology     |     Pediatrics     |     Respiratory

Therapeutic Excellence
Email Page Print Page

Prostate Cancer Clinical Trials


PSI’s key strength is predictable patient enrollment across multiple therapeutic areas, including numerous oncology indications one of which is prostate cancer.


Conducting these types of clinical trials requires thorough feasibility and the skills of the PSI project management professionals to meet goals and exceed expectations. The highly skilled and diligent clinical team manages site relationships and supports investigators as they drive towards meeting enrollment goals.


Recognizing the challenges in these type of clinical trials, PSI selects highly-experienced professional investigators who can pool a sufficient number of patients from the target population in advance.


The enrollment graphs below features studies that PSI recently conducted and reflects the actual versus planned timelines for clinical trials, reflecting PSI’s consistent performance.


For more information on PSI’s clinical trial experience in this therapeutic area, please contact us.

 


Graph 1: Phase II Hormone Refractory Prostate Cancer
Graph 1: Phase II Hormone Refractory Prostate Cancer
Graph 2: Phase III Prostate Cancer
Graph 2: Phase III Prostate Cancer


About PSI Full Service CRO Global Reach On-Time Enrollment Therapeutic Excellence News
Full Name
Email
Details

© PSI, 1995-2012. All rights reserved. | Terms of Access | Disclaimer | Privacy Policy | Sitemap

PSI on Xing PSI on Twitter PSI on Facebook PSI on Linkedin News Archives